Add like
Add dislike
Add to saved papers

The Neutrophil to Lymphocyte Ratio in Heart Failure: A Comprehensive Review.

INTRODUCTION: Heart failure (HF) and systemic inflammation are interdependent processes that continuously potentiate each other. Distinct pathophysiological pathways are activated, resulting in increased neutrophil count and reduced lymphocyte numbers, making the neutrophil to lymphocyte ratio (NLR) a potential indirect marker of severity. We conducted this comprehensive review to characterize the role of NLR in HF.

METHODS: We searched the PubMed (MEDLINE) database using the key words neutrophil", "lymphocyte", "heart failure", "cardiomyopathy", "implantable cardioverter defibrillator", "cardiac resynchronization therapy" and "heart transplant".

RESULTS: We identified 241 publications. 31 were selected for this review, including 12107 patients. NLR was correlated to HF severity expressed by clinical, biological, and imaging parameters, as well as to short and long-term prognosis. Most studies reported its survival predictive value. Elevated NLR (>2.1-7.6) was an independent predictor of in-hospital mortality [adjusted HR 1.13(95%CI 1.01-1.27)-2.8(95%CI 1.43-5.53)] as well as long-term all-cause mortality [adjusted HR 1.43(95%CI 1.1-1.85) -2.403(95%CI 1.076-5.704)]. Higher NLR levels also predicted poor functional capacity [NLR>2.26/2.74, HR 3.93(95%CI 1.02-15.12)/3.085(95%CI 1.52-6.26)], hospital readmissions [NLR>2.9/7.6, HR 1.46(95%CI 1.10-1.93)/3.46(95%CI 2.11-5.68)] cardiac resynchronization therapy efficacy [NLR>3.45/unit increase, HR 12.22(95%CI 2.16-69.05)/1.51(95%CI 1.01-2.24)] and appropriate implantable cardioverter defibrillator shocks (NLR>2.93), as well as mortality after left ventricular assist device implantation [NLR>4.4/quartiles, HR 1.67 (95%CI 1.03-2.70)/1.22 (95%CI 1.01-1.47)] or heart transplant (NLR>2.41, HR 3.403(95%CI 1.04-11.14)].

CONCLUSION: Increased NLR in HF patients can be a valuable auxiliary biomarker of severity, and most of all, of poor prognosis.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app